Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non–small cell lung cancer

MLA

Apar Kishor, Ganti, et al. “Real-World Adherence and Persistence with Anaplastic Lymphoma Kinase Inhibitors in Non–small Cell Lung Cancer.” Journal of Managed Care & Specialty Pharmacy, vol. 28, Mar. 2022, pp. 305–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....56831f7747582725293b41a5d8ee8607&authtype=sso&custid=ns315887.

APA

Apar Kishor, G., Chia-Wei, L., Erru, Y., William B, W., & Sarika, O. (2022). Real-world adherence and persistence with anaplastic lymphoma kinase inhibitors in non–small cell lung cancer. Journal of Managed Care & Specialty Pharmacy, 28, 305–314.

Chicago

Apar Kishor, Ganti, Lin Chia-Wei, Yang Erru, Wong William B, and Ogale Sarika. 2022. “Real-World Adherence and Persistence with Anaplastic Lymphoma Kinase Inhibitors in Non–small Cell Lung Cancer.” Journal of Managed Care & Specialty Pharmacy 28 (March): 305–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....56831f7747582725293b41a5d8ee8607&authtype=sso&custid=ns315887.